NCT04732429 — Methylmalonic Acidemia trial site landscape

Public-registry site landscape for NCT04732429, a Methylmalonic Acidemia study sponsored by HemoShear Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT04732429 (registry record)
Sponsor	HemoShear Therapeutics
Condition(s)	Methylmalonic Acidemia; Propionic Acidemia
Phase	PHASE2
Listed sites	16
Site countries	United States, Australia, Saudi Arabia

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT04732429 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.